Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $31.3 million.

  • Merit Medical Systems' Depreciation & Amortization (CF) rose 1860.77% to $31.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.2 million, marking a year-over-year increase of 2305.18%. This contributed to the annual value of $102.7 million for FY2024, which is 1414.01% up from last year.
  • Per Merit Medical Systems' latest filing, its Depreciation & Amortization (CF) stood at $31.3 million for Q3 2025, which was up 1860.77% from $31.0 million recorded in Q2 2025.
  • Merit Medical Systems' 5-year Depreciation & Amortization (CF) high stood at $31.3 million for Q3 2025, and its period low was $20.4 million during Q3 2022.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $21.8 million (2023), whereas its average is $23.7 million.
  • Per our database at Business Quant, Merit Medical Systems' Depreciation & Amortization (CF) crashed by 1151.53% in 2021 and then surged by 2876.59% in 2025.
  • Over the past 5 years, Merit Medical Systems' Depreciation & Amortization (CF) (Quarter) stood at $20.9 million in 2021, then dropped by 1.92% to $20.5 million in 2022, then rose by 15.29% to $23.6 million in 2023, then increased by 21.12% to $28.6 million in 2024, then increased by 9.44% to $31.3 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $31.3 million for Q3 2025, versus $31.0 million for Q2 2025 and $29.3 million for Q1 2025.